• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Clin Microbiol Infect . Evolution of viral quasispecies during SARS-CoV-2 infection

tetano

Editor, Senior Moderator
Clin Microbiol Infect


. 2020 Jul 24;S1198-743X(20)30440-7.
doi: 10.1016/j.cmi.2020.07.032. Online ahead of print.
Evolution of viral quasispecies during SARS-CoV-2 infection


A Jary[SUP] 1 [/SUP], V Leducq[SUP] 2 [/SUP], I Malet[SUP] 2 [/SUP], S Marot[SUP] 2 [/SUP], E Klement-Frutos[SUP] 3 [/SUP], E Teyssou[SUP] 2 [/SUP], C Souli?[SUP] 2 [/SUP], B Abdi[SUP] 2 [/SUP], M Wirden[SUP] 2 [/SUP], V Pourcher[SUP] 3 [/SUP], E Caumes[SUP] 3 [/SUP], V Calvez[SUP] 2 [/SUP], S Burrel[SUP] 2 [/SUP], A-G Marcelin[SUP] 2 [/SUP], D Boutolleau[SUP] 2 [/SUP]



Affiliations

Abstract

Objectives: Studies are needed to better understand the genomic evolution of the recently emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This study aimed to describe genomic diversity of SARS-CoV-2 by next generation sequencing (NGS) in a patient with longitudinal follow-up for SARS-CoV-2 infection.
Methods: Sequential samples collected from January, 29[SUP]th[/SUP] to February, 4[SUP]th[/SUP], 2020 in a patient infected by SARS-CoV-2 were used to perform amplification of two genome fragments including genes encoding Spike, Envelope, Membrane and Nucleocapsid proteins, and NGS with Illumina? technology. Phylogenetic analysis was performed with PhyML and viral variant identification with VarScan.
Results: Majority consensus sequences were identical in most of the samples (5/7) and differed with one synonymous mutation from the Wuhan reference sequence. We identified 233 variants; each sample harbored in median 38 different minority variants and only 4 were shared by different samples. The frequency of mutation was similar between genes and correlated to the gene length (r=0.93, p=0.0002). Most of mutations were substitution variations (n=217, 93.1%) and about 50% had moderate or high impact on gene expression. Viral variants also differed between lower and upper respiratory tract samples collected on the same day, suggesting independent sites of replication of SARS-CoV-2.
Conclusion: We reported for the first time minority viral population representing up to 1% during the course of SARS-CoV-2 infection. Quasispecies were different from one day to the next, as well as between anatomical sites, suggesting that this new coronavirus appears as a complex and dynamic distributions of variants in vivo.

Keywords: NGS; SARS-CoV-2; infection follow-up; minority variants; quasispecies.
 
Back
Top